198 related articles for article (PubMed ID: 36943423)
21. Applying arterial enhancement fraction (AEF) texture features to predict the tumor response in hepatocellular carcinoma (HCC) treated with Transarterial chemoembolization (TACE).
Mao X; Guo Y; Wen F; Liang H; Sun W; Lu Z
Cancer Imaging; 2021 Aug; 21(1):49. PubMed ID: 34384496
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
[TBL] [Abstract][Full Text] [Related]
23. Prediction of therapeutic response of unresectable hepatocellular carcinoma to hepatic arterial infusion chemotherapy based on pretherapeutic MRI radiomics and Albumin-Bilirubin score.
Zhao Y; Huang F; Liu S; Jian L; Xia X; Lin H; Liu J
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5181-5192. PubMed ID: 36369395
[TBL] [Abstract][Full Text] [Related]
24. Predicting the Outcome of Transcatheter Arterial Embolization Therapy for Unresectable Hepatocellular Carcinoma Based on Radiomics of Preoperative Multiparameter MRI.
Sun Y; Bai H; Xia W; Wang D; Zhou B; Zhao X; Yang G; Xu L; Zhang W; Liu P; Xu J; Meng S; Liu R; Gao X
J Magn Reson Imaging; 2020 Oct; 52(4):1083-1090. PubMed ID: 32233054
[TBL] [Abstract][Full Text] [Related]
25. Prediction of early recurrence of hepatocellular carcinoma after liver transplantation based on computed tomography radiomics nomogram.
Zhao JW; Shu X; Chen XX; Liu JX; Liu MQ; Ye J; Jiang HJ; Wang GS
Hepatobiliary Pancreat Dis Int; 2022 Dec; 21(6):543-550. PubMed ID: 35705443
[TBL] [Abstract][Full Text] [Related]
26. Quantitative analysis with multiphase contrast-enhanced computed tomography to evaluate residual tumor activity of hepatocellular carcinoma after DEB-TACE.
Hu W; Cao G; Ye S; Xu J; Chen J; Shao G
Medicine (Baltimore); 2023 Jun; 102(24):e34054. PubMed ID: 37327303
[TBL] [Abstract][Full Text] [Related]
27. A multi-institutional study to predict the benefits of DEB-TACE and molecular targeted agent sequential therapy in unresectable hepatocellular carcinoma using a radiological-clinical nomogram.
Liu K; Zheng X; Lu D; Tan Y; Hou C; Dai J; Shi W; Jiang B; Yao Y; Lu Y; Cao Q; Chen R; Zhang W; Xie J; Chen L; Jiang M; Zhang Z; Liu L; Liu J; Li J; Lv W; Wu X
Radiol Med; 2024 Jan; 129(1):14-28. PubMed ID: 37863847
[TBL] [Abstract][Full Text] [Related]
28. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
29. Development of a novel combined nomogram model integrating Rad-score, age and ECOG to predict the survival of patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
Liu A; Liu B; Duan X; Yang B; Wang Y; Dong P; Zhou P
J Gastrointest Oncol; 2022 Aug; 13(4):1889-1897. PubMed ID: 36092317
[TBL] [Abstract][Full Text] [Related]
30. Prediction of Therapeutic Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization Based on Pretherapeutic Dynamic CT and Textural Findings.
Park HJ; Kim JH; Choi SY; Lee ES; Park SJ; Byun JY; Choi BI
AJR Am J Roentgenol; 2017 Oct; 209(4):W211-W220. PubMed ID: 28813195
[TBL] [Abstract][Full Text] [Related]
31. [Prediction of short-term prognosis of hepatocellular carcinoma after TACE surgery based on MRI texture analysis technology].
Weng W; Lü XL; Zhang QQ; Zhao XM; Chen CM; Kong CL; Lu CY; Chen MJ; Ji JS
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(11):828-832. PubMed ID: 32234153
[No Abstract] [Full Text] [Related]
32. Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients.
Yuan G; Song Y; Li Q; Hu X; Zang M; Dai W; Cheng X; Huang W; Yu W; Chen M; Guo Y; Zhang Q; Chen J
Front Immunol; 2020; 11():613946. PubMed ID: 33488622
[TBL] [Abstract][Full Text] [Related]
33. Added value of CE-CT radiomics to predict high Ki-67 expression in hepatocellular carcinoma.
Zhao YM; Xie SS; Wang J; Zhang YM; Li WC; Ye ZX; Shen W
BMC Med Imaging; 2023 Sep; 23(1):138. PubMed ID: 37737166
[TBL] [Abstract][Full Text] [Related]
34. CT-Based Radiomics Nomogram: A Potential Tool for Differentiating Hepatocellular Adenoma From Hepatocellular Carcinoma in the Noncirrhotic Liver.
Nie P; Wang N; Pang J; Yang G; Duan S; Chen J; Xu W
Acad Radiol; 2021 Jun; 28(6):799-807. PubMed ID: 32386828
[TBL] [Abstract][Full Text] [Related]
35. Prognostic role of multiparameter MRI and radiomics in progression of advanced unresectable hepatocellular carcinoma following combined transcatheter arterial chemoembolization and lenvatinib therapy.
Luo J; Huang Z; Wang M; Li T; Huang J
BMC Gastroenterol; 2022 Mar; 22(1):108. PubMed ID: 35260095
[TBL] [Abstract][Full Text] [Related]
36. Role of C-arm CT for transcatheter arterial chemoembolization of hepatocellular carcinoma: diagnostic performance and predictive value for therapeutic response compared with gadoxetic acid-enhanced MRI.
Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
AJR Am J Roentgenol; 2013 Sep; 201(3):675-83. PubMed ID: 23971463
[TBL] [Abstract][Full Text] [Related]
37. CT texture analysis in predicting treatment response and survival in patients with hepatocellular carcinoma treated with transarterial chemoembolization using random forest models.
An H; Bhatia I; Cao F; Huang Z; Xie C
BMC Cancer; 2023 Mar; 23(1):201. PubMed ID: 36869284
[TBL] [Abstract][Full Text] [Related]
38.
Hu S; Kang Y; Xie Y; Yang T; Yang Y; Jiao J; Zou Q; Zhang H; Zhang Y
Abdom Radiol (NY); 2023 Feb; 48(2):532-542. PubMed ID: 36370179
[TBL] [Abstract][Full Text] [Related]
39. Selection Between Liver Resection Versus Transarterial Chemoembolization in Hepatocellular Carcinoma: A Multicenter Study.
Fu S; Wei J; Zhang J; Dong D; Song J; Li Y; Duan C; Zhang S; Li X; Gu D; Chen X; Hao X; He X; Yan J; Liu Z; Tian J; Lu L
Clin Transl Gastroenterol; 2019 Aug; 10(8):e00070. PubMed ID: 31373932
[TBL] [Abstract][Full Text] [Related]
40. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
